Genotoxic and immunotoxic effects of cellulose nanocrystals in vitro

Environmental and Molecular Mutagenesis

Volumn 56, Issue 2, 2015, Pages 171-182

  Catalán, Julia ^a,b   Ilves, Marit ^a   Järventaus, Hilkka ^a   Hannukainen, Kati Susanna ^a   Kontturi, Eero ^c   Vanhala, Esa ^a   Alenius, Harri ^a   Savolainen, Kai M ^a   Norppa, Hannu ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c AALTO UNIVERSITY   (Finland)

Author keywords

Genotoxicity; Inflammation; Micronucleus; Nanocellulose

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELLULOSE; CELLULOSE NANOCRYSTAL; INTERLEUKIN 1BETA; MICROCRYSTALLINE CELLULOSE; NANOCRYSTAL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOTOXIN; MUTAGENIC AGENT; NANOPARTICLE;

ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; CYTOTOXICITY TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOTOXICITY; IN VITRO STUDY; MACROPHAGE; MICRONUCLEUS; PARTICLE SIZE; ATOMIC FORCE MICROSCOPY; BRONCHUS; CELL CYCLE; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOLOGY; INFLAMMATION; MICRONUCLEUS TEST; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

BRONCHI; CELL CYCLE; CELL LINE; CELLULOSE; EPITHELIAL CELLS; HUMANS; IMMUNOTOXINS; INFLAMMATION; MICRONUCLEUS TESTS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MUTAGENS; NANOPARTICLES;

EID: 84925281071     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21913     Document Type: Article

References (51)

1. Catalán J, Järventaus H, Vippola M, Savolainen K, Norppa H. 2012. Induction of chromosomal aberrations by carbon nanotubes and titanium dioxide nanoparticles in human lymphocytes in vitro. Nanotoxicology 6:825-836.
2. Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, Takata M, Lever IJ, Nanchahal J, Fanselow MS, Maze M. 2010. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol 68:360-368.
3. Clift MJD, Foster EJ, Vanhecke D, Studer D, Wick P, Gehr P, Rothen-Rutishauser B, Weder C. 2011. Investigating the interaction of cellulose nanofibers derived from cotton with a sophisticated 3D human lung cell coculture. Biomacromolecules 12:3666-3673.
4. Cullen RT, Miller BG, Clark S, Davis JMG. 2002a. Tumorigeniticity of cellulose fibers injected into the rat peritoneal cavity. Inhal Toxicol 14:685-703.
5. Cullen RT, Miller BG, Jones AD, Davis JMG. 2002b. Toxicity of cellulose fibres. Ann Occup Hyg 46:81-84.
6. de Lima R, Oliveira Feitosa L, Rodrigues Maruyama C, Abreu Barga M, Yamawaki PC, Vieira IJ, Teixeira EM, Corrêa AC, Caparelli Mattoso LH, Fernandes Fraceto L. 2012. Evaluation of the genotoxicity of cellulose nanofibers. Int J Nanomedicine 7:3555-3565.
7. Dinarello CA. 2011. A clinical perspective of IL-1b as the gatekeeper of inflammation. Eur J Immunol 41:1203-1217.
8. Doak SH, Manshian B, Jenkins GJS, Singh N. 2012. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. Mutat Res 745:104-111.
9. Donaldson K, Poland CA, Schins RP. 2010. Possible genotoxic mechanisms of nanoparticles: Criteria for improved test strategies. Nanotoxicology 4:414-420.
10. Dong XM, Revol J-F, Gray DG. 1998. Effect of microcrystalline preparation conditions on the formation of colloid crystals of cellulose. Cellulose 5:19-32.
11. Edgar CD, Gray DG. 2003. Smooth model cellulose I surfaces from nanocrystals suspensions. Cellulose 10:299-306.
12. Emerit I. 2007. Clastogenic factors as potential biomarkers of increased superoxide production. Biomark Insights 2:429-438.
13. Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084-1104.
14. Fleming K, Gray DG, Matthews S. 2001. Cellulose crystallites. Chem Eur J 7:1831-1835.
15. Galloway S. 2000. Cytotoxicity and chromosome aberrations in vitro: Experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ Mol Mutagen 35:191-201.
16. Gaspar D, Fernandes SN, de Oliveira AG, Fernandes JG, Grey P, Pontes RV, Pereira L, Martins R, Godinho MH, Fortunato E. 2014. Nanocrystalline cellulose applied simultaneously as the gate dielectric and the substrate in flexible field effect transistors. Nanotechnology 25(9):094008.
17. Gonzalez L, Sanderson BJS, Kirsch-Volders M. 2011. Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials. Mutagenesis 26:185-191.
18. Guadagnini R, Halamoda Kenzaoui B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, Saunders M, Juillerat L, Marcomini A, Huk A, et al. 2013. Toxicity screening of nanomaterials: Challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology [Epub ahead of print].
19. Habibi Y, Lucia LA, Rojas OJ. 2010. Cellulose nanocrystals: Chemistry, self-assembly, and applications. Chem Rev 110:3479-3500.
20. Jenny M, Schroecksnadel S, Fuchs D. 2011.Testing for immunomodulatory properties of nanoparticles. J Biomed Nanotechnol 7:11-12.
21. Kawai T, Takeuchi O, Fujita T, Inoue J, Mühlradt PF, Sato S, Hoshino K, Akira S 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167:5887-5894.
22. Kirsch-Volders M, Fenech M. 2001. Inclusion of micronuclei in non-divided mononuclear lymphocytes and necrosis/apoptosis may provide a more comprehensive cytokinesis block micronucleus assay for biomonitoring purposes. Mutagenesis 16:51-58.
23. Kisin ER, Murray AR, Sargent L, Lowry D, Chirila M, Siegrist KJ, Schwegler-Berry D, Leonard S, Castranova V, Fadeel B, et al. 2011. Genotoxicity of carbon nanofibers: Are they potentially more or less dangerous than carbon nanotubes or asbestos? Toxicol Appl Pharmacol 252:1-10.
24. Klemm D, Kramer F, Moritz S, Lindström T, Ankerfors M, Gray D, Dorris A. 2011. Nanocelluloses: A new family of nature-based materials. Angew Chem Int Ed Engl 50:5438-5466.
25. Kontturi E, Johansson LS, Kontturi KS, Ahonen P, Thüne PC, Laine J 2007. Cellulose nanocrystals submonolayers by spin coating. Langmuir 23:9674-9680.
26. Kovacs T, Naish V, O'Connor B, Blaise C, Gagné F, Hall L, Trudeau V, Martel P. 2010. An ecotoxicological characterization of nanocrystalline cellulose (NCC). Nanotoxicology 4:255-270.
27. Kraus T, Pfahlberg A, Zobelein P, Gefeller O, Raithel HJ. 2004. Lung function among workers in the soft tissue paper-producing industry. Chest 125:731-736.
28. Lam E, Male KB, Chong JH, Leung AC, Luong JH. 2012. Applications of functionalized and nanoparticle-modified nanocrystalline cellulose. Trends Biotechnol 30:283-290.
29. Lindberg HK, Falck GCM, Suhonen S, Vippola M, Vanhala E, Catalán J, Savolainen K, Norppa H. 2009. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicol Lett 186:166-173.
30. Lindholm C, Acheva A, Salomaa S. 2010. Clastogenic plasma factors: A short overview. Radiat Environ Biophys 49:133-138.
31. Magdolenova Z, Collins A, Kumar A, Dhawan A, Stone V, Dusinska M. 2014. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. Nanotoxicology 8:233-278.
32. Male KB, Leung ACW, Montes J, Kamen A, Luong JHT. 2012. Probing inhibitory effects of nanocrystalline cellulose: Inhibition versus surface charge. Nanoscale 4:1373-1379.
33. Mogensen TH. 2009. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22:240-273.
34. Moreira S, Silva NB, Almeida-Lima J, Rocha HA, Medeiros SR, Alves C Jr, Gama FM. 2009. BC nanofibres: in vitro study of genotoxicity and cell proliferation. Toxicol Lett 189:235-241.
35. Mukhopadhyay S, Hoidal JR, Mukherjee TK. 2006. Role of TNFα in pulmonary pathophysiology. Respirat Res 7:125.
36. Norppa H, Falck GC. 2003. What do human micronuclei contain? Mutagenesis 18:221-233.
37. OECD Guideline for testing of chemicals, OECD 487. In Vitro Mammalian Cell Micronucleus Test (MNvit), Adopted 23 July 2010.
38. OECD (2014) Draft Guidance Document on the use of OECD Test Guidelines on genotoxicity testing for manufactured nanomaterials (http://www.oecd.org/env/ehs/testing/Draft_GD_nano_and_genotox_rev2.pdf).
39. Palomäki J, Välimäki E, Sund J, Vippola M, Clausen PA, Jensen KA, Savolainen K, Matikainen S, Alenius H 2011. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 5:6861-6870.
40. Pértile RA, Moreira S, Costa RM, Correia A, Guardão L, Gartner F, Vilanova M, Gama M. 2012. J Biomater Sci Polym Ed 23:1339-1354.
41. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423-428.
42. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris CC. 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48:1904-1909.
43. Rosenbruch M, Friedrichs KH, Schlipköter H-W. 1992. Zur gesundheitlichen Bedeutung der zur Herstellung von Faserzemont verwendeten Asbestersatzfasern. Zbl Arbeitsmed 42:355-362.
44. Sargent LM, Hubbs AF, Young SH, Kashon ML, Dinu CZ, Salisbury JL, Benkovic SA, Lowry DT, Murray AR, Kisin ER, et al. 2012. Single-walled carbon nanotube-induced mitotic disruption. Mutat Res 745:28-37.
45. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140:821-832.
46. Shvedova AA, Yanamala N, Kisin ER, Tkach AV, Murray AR, Hubbs A, Chirila MM, Keohavong P, Sycheva LP, Kagan VE, Castranova V. 2014. Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: One year postexposure comparisons. Am J Physiol Lung Cell Mol Physiol 306:L170-L182.
47. Surrallés J, Xamena N, Creus A, Catalán J, Norppa H, Marcos R. 1995. Induction of micronuclei by five pyrethroid insecticides in whole-blood and isolated human lymphocyte cultures. Mutat Res 341:169-184.
48. Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, Kitajima S, Kanno J. 2008. Induction of mesothelioma in p53 § mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 33:105-116.
49. Vartiainen J, Pöhler T, Sirola K, Pylkkänen L, Alenius H, Hokkinen J, Tapper U, Lahtinen P, Kapanen A, Putkisto K, et al. 2011. Health and environmental safety aspects of friction grinding and spray drying of microfibrillated cellulose. Cellulose 18:775-786.
50. Yanamala N, Farcas MT, Hatfield MK, Kisin ER, Kagan VE, Geraci CL, Shvedova AA. 2014. In vivo evaluation of the pulmonary toxicity of cellulose nanocrystals: A renewable and sustainable nanomaterial of the future. ACS Sustainable Chem Eng DOI:10.1021/sc500153k.
51. Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J. 2010. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci USA 107:19449-19454.